Leishmaniasis is a neglected disease and drugs approved for its treatment often lead to
abandonment, failure of therapy and even death. Photodynamic therapy (PDT) has been
shown to be a promising, non-invasive and selective for a target region without requiring
high-cost technology. Usually, it is employed a photosensitizing agent (PS) incorporated into
nanoparticles (NP). Pluronics® P-123 and F-127 micelles are very interesting aqueous NP
promoting efficient and selective delivery and less adverse effects. This study aimed to …